| Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention LH Cavallari, CR Lee, AL Beitelshees, RM Cooper-DeHoff, JD Duarte, ... JACC: Cardiovascular Interventions 11 (2), 181-191, 2018 | 286 | 2018 |
| Pharmacotherapy update on the use of vasopressors and inotropes in the intensive care unit JC Jentzer, JC Coons, CB Link, M Schmidhofer Journal of cardiovascular pharmacology and therapeutics 20 (3), 249-260, 2015 | 215 | 2015 |
| Multisite Investigation of Strategies for the Implementation of CYP2C19 Genotype‐Guided Antiplatelet Therapy PE Empey, JM Stevenson, S Tuteja, KW Weitzel, DJ Angiolillo, ... Clinical Pharmacology & Therapeutics 104 (4), 664-674, 2018 | 130 | 2018 |
| Pulmonary arterial hypertension: a pharmacotherapeutic update JC Coons, K Pogue, AR Kolodziej, GA Hirsch, MP George Current cardiology reports 21, 1-12, 2019 | 101 | 2019 |
| Advancing pharmacogenomics education in the core PharmD curriculum through student personal genomic testing SM Adams, KB Anderson, JC Coons, RB Smith, SM Meyer, LS Parker, ... American journal of pharmaceutical education 80 (1), 3, 2016 | 89 | 2016 |
| Pharmacotherapy for acute heart failure syndromes JC Coons, M McGraw, S Murali American Journal of Health-System Pharmacy 68 (1), 21-35, 2011 | 84 | 2011 |
| Effectiveness and safety of direct oral anticoagulants versus warfarin in obese patients with acute venous thromboembolism JC Coons, L Albert, A Bejjani, CJ Iasella Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 40 (3 …, 2020 | 83 | 2020 |
| An evidence based systematic review of remifentanil associated opioid-induced hyperalgesia RM Rivosecchi, MJ Rice, PL Smithburger, MS Buckley, JC Coons, ... Expert opinion on drug safety 13 (5), 587-603, 2014 | 82 | 2014 |
| Precision pharmacotherapy: integrating pharmacogenomics into clinical pharmacy practice JK Hicks, CL Aquilante, HM Dunnenberger, RS Gammal, RS Funk, ... Journal of the American College of Clinical Pharmacy 2 (3), 303-313, 2019 | 69 | 2019 |
| Performance of anti-factor Xa versus activated partial thromboplastin time for heparin monitoring using multiple nomograms E Whitman-Purves, JC Coons, T Miller, JV DiNella, A Althouse, ... Clinical and Applied Thrombosis/Hemostasis 24 (2), 310-316, 2018 | 56 | 2018 |
| CYP2C19 Genotype‐Guided Antiplatelet Therapy After Percutaneous Coronary Intervention in Diverse Clinical Settings AL Beitelshees, CD Thomas, PE Empey, GA Stouffer, DJ Angiolillo, ... Journal of the American Heart Association 11 (4), e024159, 2022 | 55 | 2022 |
| Evidence for simulation in pharmacy education AL Seybert, PL Smithburger, NJ Benedict, LR Kobulinsky, SL Kane‐Gill, ... Journal of the American College of Clinical Pharmacy 2 (6), 686-692, 2019 | 50 | 2019 |
| Triple antithrombotic therapy with aspirin, P2Y12 inhibitor, and warfarin after percutaneous coronary intervention: an evaluation of prasugrel or ticagrelor versus clopidogrel NJ Verlinden, JC Coons, CJ Iasella, SL Kane-Gill Journal of Cardiovascular Pharmacology and Therapeutics 22 (6), 546-551, 2017 | 46 | 2017 |
| Impact of the CYP2C19*17 Allele on Outcomes in Patients Receiving Genotype‐Guided Antiplatelet Therapy After Percutaneous Coronary Intervention CR Lee, CD Thomas, AL Beitelshees, S Tuteja, PE Empey, JC Lee, ... Clinical Pharmacology & Therapeutics 109 (3), 705-715, 2021 | 44 | 2021 |
| 2007 guideline update for unstable angina/non–ST-segment elevation myocardial infarction: focus on antiplatelet and anticoagulant therapies JC Coons, S Battistone Annals of Pharmacotherapy 42 (7-8), 989-1001, 2008 | 36 | 2008 |
| Hydroxymethylglutaryl-coenzyme A reductase inhibitors in osteoporosis management JC Coons Annals of Pharmacotherapy 36 (2), 326-330, 2002 | 36 | 2002 |
| Survey of anticoagulation practices with the Impella percutaneous ventricular assist device at high‐volume centers BN Reed, RJ DiDomenico, JE Allender, JC Coons, JF Cox, D Johnson, ... Journal of Interventional Cardiology 2019 (1), 3791307, 2019 | 33 | 2019 |
| Eptifibatide-associated acute, profound thrombocytopenia JC Coons, RA Barcelona, T Freedy, MF Hagerty Annals of Pharmacotherapy 39 (2), 368-372, 2005 | 32 | 2005 |
| Multidisciplinary team for enhancing care for patients with acute myocardial infarction or heart failure JC Coons, T Fera American Journal of Health-System Pharmacy 64 (12), 1274-1278, 2007 | 31 | 2007 |
| Disopyramide for hypertrophic cardiomyopathy: a pragmatic reappraisal of an old drug NJ Verlinden, JC Coons Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 35 (12 …, 2015 | 30 | 2015 |
